We Had the Vaccine the Whole Time
We Had the Vaccine the Whole Time You may be surprised to learn that of the trio of long-awaited coronavirus vaccines, the most promising, Moderna’s mRNA-1273, which reported a 94.5 percent efficacy rate on November 16, had been designed by January 13.covid-19vaccineLINK